BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25781885)

  • 1. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
    Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
    PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma.
    Li FJ; Tsuyama N; Ishikawa H; Obata M; Abroun S; Liu S; Otsuyama K; Zheng X; Ma Z; Maki Y; Kawano MM
    Blood; 2005 Apr; 105(8):3295-302. PubMed ID: 15626731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
    Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
    Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
    Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
    Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 translocation to lipid rafts: signaling requirements and downstream biological events.
    Nadiri A; Polyak MJ; Jundi M; Alturaihi H; Reyes-Moreno C; Hassan GS; Mourad W
    Eur J Immunol; 2011 Aug; 41(8):2358-67. PubMed ID: 21567389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin enhances human beta-defensin-2 production in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2008 Oct; 149(10):5189-98. PubMed ID: 18556347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
    Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
    Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine signaling: STATS in plasma membrane rafts.
    Sehgal PB; Guo GG; Shah M; Kumar V; Patel K
    J Biol Chem; 2002 Apr; 277(14):12067-74. PubMed ID: 11815625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
    Lo RK; Wise H; Wong YH
    Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production.
    Zhang M; Moran M; Round J; Low TA; Patel VP; Tomassian T; Hernandez JD; Miceli MC
    J Immunol; 2005 Feb; 174(3):1479-90. PubMed ID: 15661907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever.
    Shah M; Patel K; Fried VA; Sehgal PB
    J Biol Chem; 2002 Nov; 277(47):45662-9. PubMed ID: 12235142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
    Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
    Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
    Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
    Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of IL-8 expression by Cordyceps militaris grown on germinated soybeans through lipid rafts formation and signaling pathways via ERK and JNK in A549 cells.
    Han JY; Im J; Choi JN; Lee CH; Park HJ; Park DK; Yun CH; Han SH
    J Ethnopharmacol; 2010 Jan; 127(1):55-61. PubMed ID: 19799982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
    Buk DM; Waibel M; Braig C; Martens AS; Heinrich PC; Graeve L
    J Cell Sci; 2004 Apr; 117(Pt 10):2063-75. PubMed ID: 15054106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.
    Yang J; Zhang X; Wang J; Qian J; Zhang L; Wang M; Kwak LW; Yi Q
    Blood; 2007 Oct; 110(8):3028-35. PubMed ID: 17644731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.